The DOI matches its Crossref record; 312 of the 321 references it cites were found in a registry or an index.
Allergen injection immunotherapy for seasonal allergic rhinitis
Open accessAbstract
BACKGROUND: Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its pharmacological treatment, its prevalence has increased worldwide. For patients whose symptoms remain uncontrolled despite medical treatment, allergen injection immunotherapy is advised. An allergen-based treatment may reduce symptoms, the need for medication and modify the natural course of this disease. OBJECTIVES: To evaluate the efficacy and safety of subcutaneous specific allergen immunotherapy, compared with placebo, for reducing symptoms and medication requirements in seasonal allergic rhinitis patients. SEARCH STRATEGY: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 1 2006), MEDLINE (1950 to 2006), EMBASE (1974 to 2006), Pre-MEDLINE, KOREAMED, INDMED, LILACS, PAKMEDINET, Scisearch, mRCT and the National Research Register. The date of the last search was February 2006. SELECTION CRITERIA: All studies identified by the searches were assessed to identify randomised controlled trials involving participants with symptoms of seasonal allergic rhinitis and proven allergen sensitivity, treated with subcutaneous allergen specific immunotherapy or corresponding placebo. DATA COLLECTION AND ANALYSIS: Two independent authors identified all studies reporting double-blind, placebo controlled randomised trials of specific immunotherapy in patients with seasonal allergic rhinitis due to tree, grass or weed pollens. Two authors independently performed quality assessment of studies. Data from identified studies were abstracted onto a standard extraction sheet and subsequently entered into RevMan 4.2.8. Analysis was performed using the Standardised Mean Difference (SMD) method and a random-effects model; P values < 0.05 were considered statistically significant. The primary outcome measures were symptom scores, medication use, quality of life and adverse events. MAIN RESULTS: We retrieved 1111 publications of which 51 satisfied our inclusion criteria. In total there were 2871 participants (1645 active, 1226 placebo), each receiving on average 18 injections. Duration of immunotherapy varied from three days to three years. Symptom score data from 15 trials were suitable for meta-analysis and showed an overall reduction in the immunotherapy group (SMD -0.73 (95% CI -0.97 to -0.50, P < 0.00001)). Medication score data from 13 trials showed an overall reduction in the immunotherapy group (SMD of -0.57 (95% CI -0.82 to -0.33, p<0.00001)). Clinical interpretation of the effect size is difficult. Adrenaline was given in 0.13% (19 of 14085 injections) of those on active treatment and in 0.01% (1 of 8278 injections) of the placebo group for treatment of adverse events. There were no fatalities. AUTHORS' CONCLUSIONS: This review has shown that specific allergen injection immunotherapy in suitably selected patients with seasonal allergic rhinitis results in a significant reduction in symptom scores and medication use. Injection immunotherapy has a known and relatively low risk of severe adverse events. We found no long-term consequences from adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Total symptom score is the main variable in systematic reviews and meta-analyses, both in SCIT [172] and in SLIT in drops [173] or in tablets [174]; therefore, specific data on NO are not usually published [171].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Beasley, R. W. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07302-9 · Cited by 3,794
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R. F., & Malling, H. ‐. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,582
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E., Jacobson, M. R., O'Brien, F., Noble, W. J., Till, S. J., Hamid, Q. A., & Nouri‐Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,371
Self-citationMöller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Flagged first, then by citations
9 of the 321 references couldn’t be matched to a known paper.
Research works printed but not linked: 29
- Brewczynski, 1999, Efficacy and safety of immunotherapy with modified grass pollen allergens. Results of a placebo-controlled study, Allergologie, 22, 411
- Hauser, 1995, Inhibitory effect on migration of inflammatory cells into the nasal mucosa by immunotherapy, Allergo Journal, 4, 164
- Berstein, 2001, Double blind placebo controlled (DBPC) study of grapeseed extract in the treatment of seasonal allergic rhinitis (SAR), Journal of Allergy and Clinical Immunology, 107, S311
- Calderon, 2003, Double blind placebo controlled study of specific immunotherapy (SIT) with Alutard SQ grass pollen for seasonal allergic rhinoconjunctivitis, Allergy and Clinical Immunology International, 1, Abstract No. O-
- Crimi, 2001, A randomised double-blind study of specific immunotherapy (SIT) in patients with seasonal allergic-rhinitis: effects on clinical and inflammatory markers, European Respiratory Journal, 18, 482s
- Egger, 1997, The influence of hypo-sensitisation therapy on the sense of smell in subjects with seasonal allergic rhinitis, Allergologie, 20, 525
- Frankland, 1963, Treatment of hay fever by depot injection (shypyrindene) in allergic conditions. Double blind clinical study, Acta Allergologica, 18, 175
- Kerr, 1964, The treatment of hay fever including a controlled trial of the use of alum precipitate pollen adsorbate, Acta Allergologica, 19, 76
- Kuhn, 1985, Hyposensitization in pollen sensitive children: A 3 year prospective study, Allergologie, 8, 103
- Lindsay-Miller, 1971, Pollen Tyrosine in the treatment of hay fever, Clinical Allergy, 1, 351
- Malling, 2000, Allergen specific immunotherapy for asthma, Ugeskr Laeger, 162 (4), 477
- Manger, 1984, Hyposensitization of hay fever patients with Tyrosin-adsorbed grass and rye pollen allergoid. Clinical and immunological parameters during different dosages with TA Tyrosin-Allergoid Gräserpollen, Allergologie, 7, 222
- Mewes, 1999, Short term immune therapy with ALK7 reduces grass-pollen induces rhinoconjunctivitis symptoms and the specific nasal reactivity is more efficient than a symptomatic standard therapy, Allergologie, 22, 581
- Nolte, 1999, Allergen extracts, dosing, efficacy and safety of immunotherapy, International Review of Allergology and Clinical Immunology, 5 (3), 184
- Osterballe, 1982, Immunotherapy in hay fever with timothy major allergens, Allergy, 37, 8
- Pastorello, 1988, A double blind placebo controlled trial of specific immunotherapy with aluminium hydroxide adsorbed allergoid in grass pollen induced rhinitis, Allergy, 43, 48
- Ricca, 1997, Preseasonal specific immunotherapy with modified Phleum pratense allergenic extracts: tolerability and effects, Allergologia et Immunopathologia (Madrid), 25, 167
- Rozniecka, 1995, The characteristics of pollinosis during the pollen season and the influence of specific immunotherapy. Part II: Cytologic changes and chemotactic activity in nasal lavage, Pneumonologia i Alergologia Polska, 63, 144
- Ruiz, 2001, Safety and efficacy of immunotherapy with a standardized depigmented and glutaraldehyde-polyerized extract of phleum pratense pollen, Journal of Allergy and Clinical Immunology, 107, S260
- Sandstrom, 2001, Xolair is effective in the treatment of seasonal birch pollen allergic rhinitis, Annals of Allergy, Asthma and Immunology, 86, 83
- Stuck, 2001, Birch pollen allergoid plus MPL in short-term immunotherapy, Otolaryngology - Head and Neck Surgery, 125, P199
- Sykora, 2004, Efficacy and safety of specific allergen immunotherapy with standardized depod allergen H-AI depot (pollens), Alergie, 6, 170
- Watanabe, 2003, Successful grass pollen immunotherapy inhibits eosinophil accumulation in the nasal mucosa: role of adhesion molecules and apoptosis [Abstract], Allergy and Clinical Immunology International, 15, Abstract No.O-1
- Williams, 2001, A study to determine the efficacy of a nasally administered rye grass peptide, Ptl-0901, in the treatment of severe seasonal hayfever, Journal of Allergy and Clinical Immunology, 107, S256
- Williams, 2002, Effectiveness of preseasonal allergoid immunotherapy in patients with grass pollen allergy [Abstract], Allergy, 57, 51
- Yariktas, 2002, Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis, Turkish Archives of Otolaryngology, 40, 252
- Frank, 2001, Effectiveness of a pre-seasonal allergoid immunotherapy in patients with seasonal allergic rhinitis due to grass pollen, Journal of Allergy and Clinical Immunology, 107, S260
- Committee of the Safety of Medicine, 1994, Desensitising vaccines: New advice, Current Problems in Pharmacovigilance, 20, 5
- Durham, 1999, Long-term clinical efficacy of grass-pollen immunotherapy, New England Journal of Medicine, 341(7), 468, 10.1056/NEJM199908123410702 · DOI
Cited by
Sorted by citations
Items 101–200 of 674
Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy
Pipet, A., Botturi, K., Pinot, D., VERVLOET, D., & Magnan, A. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.01.008 · Cited by 75
Position Paper on Nasal Obstruction: Evaluation and Treatment
SEAIC Rhinoconjunctivitis Committee & SEORL Rhinology, A., Valero, A., Navarro, A., del Cuvillo, A., Alobid, I., Benito, Jr., Colás, C., de los Santos, G., Fernández Liesa, R., García-Lliberós, A., et al. (2018) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0232 · Cited by 76
Valovirta, E. J., Berstad, A. K. H., Jacques de, B. L. I. C., Bufe, A., Eng, P. A., Halken, S., Ojeda, P., Roberts, G. C., Tommerup, L., Varga, E., et al. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.013 · Cited by 76
Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
Nurmatov, U. B., Dhami, S., Arasi, S., Roberts, G. C., Pfaar, O., Muraro, A. M., Ansotegui, I. J., Calderón, M. A., Cingi, C., Durham, S. R., et al. (2017) · Clinical and Translational Allergy · doi:10.1186/s13601-017-0159-6 · Cited by 75
Self-citationAllergen-specific immunotherapy
Moote, W., Kim, H. L., & Ellis, A. K. (2018) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0282-5 · Cited by 74
House dust mite sublingual immunotherapy: Results of a US trial
Bush, R. K., Swenson, C. A., Fahlberg, B., Evans, M. D., Esch, R. E., & Busse, W. W. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.045 · Cited by 73
New approaches to allergen immunotherapy
Gunawardana, N. C., & Durham, S. R. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.07.014 · Cited by 72
Self-citationJacobsen, L., Wahn, U., & Bilò, M. B. (2012) · Clinical and Translational Allergy · doi:10.1186/2045-7022-2-8 · Cited by 71
Jensen‐Jarolim, E., Bachmann, M. F., Bonini, S., Jacobsen, L., Jutel, M., Klimek, L., Mahler, V., Mösges, R., Moingeon, P. E., O’Hehir, R. E., et al. (2019) · Allergy · doi:10.1111/all.14134 · Cited by 72
Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT
Zissler, U., Jakwerth, C., Guerth, F. M., Pechtold, L., Aguilar-Pimentel, J. A., Dietz, K., Suttner, K., Piontek, G., Haller, B., Hajdu, Z., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.016 · Cited by 68
Sublingual immunotherapy for treating allergic conjunctivitis
Calderón, M. A., Penagos, M., Sheikh, A., Canonica, G. W., & Durham, S. R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007685.pub2 · Cited by 71
Self-citationCD‐sens: a biological measure of immunological changes stimulated by ASIT
Nopp, A., Cardell, L. O., Johansson, S. G. O., & Öman, H. (2009) · Allergy · doi:10.1111/j.1398-9995.2008.01900.x · Cited by 67
Pfaar, O., Urry, Z., Robinson, D. S., SAGER, A. R., Richards, D. F., Hawrylowicz, C. M., Bräutigam, M., & Klimek, L. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02736.x · Cited by 69
Piconi, S., Trabattoni, D., Rainone, V., Borgonovo, L., Passerini, S., Rizzardini, G., Frati, F., Iemoli, E., & Clerici, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002465 · Cited by 66
Subcutaneous Immunotherapy Versus Sublingual Immunotherapy: Which Is More Effective?
Nelson, H. S. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.11.018 · Cited by 66
von Hertzen, L. C., Savolainen, J., Hannuksela, M., Klaukka, T., Lauerma, A., Mäkelä, M. J., Pekkanen, J., Pietinalho, A., Vaarala, O., Valovirta, E. J., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02024.x · Cited by 64
Update in the Mechanisms of Allergen-Specific Immunotheraphy
Akkoç, T., Akdiş, M., & Akdiş, C. A. (2010) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2011.3.1.11 · Cited by 66
Pfaar, O., & Klimek, L. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60451-6 · Cited by 65
Chaker, A. M., Shamji, M. H., Dumitru, F. A., Calderón, M. A., Scadding, G. W., Makatsori, M., Jones, I., He, Q. A., Subramanian, K. K., Arm, J. P., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.046 · Cited by 64
Self-citationKlimek, L., Schendzielorz, P., Pinol, R., & Pfaar, O. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.03971.x · Cited by 63
Samolinski, B. K., Fronczak, A., Kuna, P., Akdiş, C. A., Anto, J. M., Białoszewski, A. Z., Burney, P., Bush, A., Czupryniak, A., Dahl, R., et al. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02822.x · Cited by 63
Waldinger, M. D., Meinardi, M. M. H. M., & Schweitzer, D. H. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02167.x · Cited by 61
Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen
Kleine‐Tebbe, J., Bergmann, K., Friedrichs, F., Fuchs, T., Jung, K., Klimek, L., Kühr, J., Lässig, W., Lepp, U. S., Niggemann, B., et al. (2006) · Allergologie · doi:10.5414/alp29135 · Cited by 61
Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents
Halken, S., Agertoft, L., Seidenberg, J., Bauer, C., Payot, F., Martín‐Muñoz, M. F., Bartkowiak-Emeryk, M., Vereda, A., Jean-Alphonse, S., Mélac, M., et al. (2010) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2010.01050.x · Cited by 59
Ellis, A. K., Frankish, C. W., O’Hehir, R. E., Armstrong, K., Steacy, L. M., Larché, M., & Hafner, R. P. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.11.043 · Cited by 60
Allergen-specific immunotherapy of Hymenoptera venom allergy – also a matter of diagnosis
Schiener, M., Graessel, A., Ollert, M. W., Schmidt‐Weber, C. B., & Blank, S. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1334745 · Cited by 60
Current Management of Allergic Rhinitis
Klimek, L., Mullol, J., Ellis, A. K., Izquierdo-Domínguez, A., Hagemann, J., Casper, I., Davis, A., & Becker, S. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.03.023 · Cited by 64
Schmid, J. M., Würtzen, P. A., Dahl, R., & Hoffmann, H. J. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.023 · Cited by 58
Specific allergen immunotherapy for the treatment of atopic eczema
Tam, H. H. Y., Calderón, M. A., Manikam, L., Nankervis, H., Núñez, I. G., Williams, H. C., Durham, S. R., & Boyle, R. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008774.pub2 · Cited by 58
Self-citationPatil, S. U., & Shreffler, W. G. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04503.x · Cited by 58
Devillier, P., Gall, M. L., & Horak, F. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02473.x · Cited by 59
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
Klimek, L., Kündig, T. M., Kramer, M. F., Guethoff, S., Jensen‐Jarolim, E., Schmidt‐Weber, C. B., Palomares, O., Mohsen, M. O., Jakob, T., & Bachmann, M. F. (2018) · Allergo Journal International · doi:10.1007/s40629-018-0074-y · Cited by 57
Initial immunological changes as predictors for house dust mite immunotherapy response
Gómez, E., Fernández, T. D., Doña, I., Rondón, C., Campo, P., Gómez, F., Salas, M. L., González, M., Perkins, J. R., Palomares, F., et al. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12578 · Cited by 57
Braun, J.-J., Devillier, P., Wallaert, B., Rancé, F., Jankowski, R., Acquaviva, J.-T., Beley, G., & Demoly, P. M. (2010) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(10)70012-7 · Cited by 56
Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review
Tam, H. H. Y., Calderón, M. A., Manikam, L., Nankervis, H., Núñez, I. G., Williams, H. C., Durham, S. R., & Boyle, R. J. (2016) · Allergy · doi:10.1111/all.12932 · Cited by 57
Self-citationRodríguez‐Pérez, N., Ambriz-Moreno, M. D. J., Canonica, G. W., & Penagos, M. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60496-6 · Cited by 56
Allergen Immunotherapy in Allergic Respiratory Diseases
Viswanathan, R. K., & Busse, W. W. (2012) · CHEST Journal · doi:10.1378/chest.11-2800 · Cited by 56
One hundred years of allergen immunotherapy: Time to ring the changes
Durham, S. R., & Leung, D. Y. M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.032 · Cited by 56
Self-citationCurrent therapeutical strategies for allergic rhinitis
Klimek, L., Sperl, A., Becker, S., Mösges, R., & Tomazic, P. V. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1543401 · Cited by 56
Kim, J. Y., Jang, M., Kim, D., Park, S., & Han, D. H. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.08.018 · Cited by 56
Häfner, D., Reich, K., Matricardi, P. M., Meyer, H. E., Kettner, J., & Narkus, A. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02531.x · Cited by 55
Dranitsaris, G., & Ellis, A. K. (2014) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12112 · Cited by 54
Becker, S., Schlederer, T., Kramer, M., Haack, M., Vrtala, S., Resch, Y., Lupinek, C., Valenta, R., & Gröger, M. (2016) · International Archives of Allergy and Immunology · doi:10.1159/000447694 · Cited by 54
Cox, L., & Calderón, M. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.528647 · Cited by 53
Duration of allergen immunotherapy for inhalant allergy
Penagos, M., & Durham, S. R. (2019) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000585 · Cited by 53
Self-citationEguíluz‐Gracia, I., Fernández‐Santamaría, R., Testera‐Montes, A., Ariza, A., Campo, P., Prieto, A., Pérez‐Sánchez, N., Salas, M. L., Mayorga, C., Torres, M. J., et al. (2020) · Allergy · doi:10.1111/all.14206 · Cited by 52
Zhang, L., Wang, C., Han, D., Wang, X., Zhao, Y., & Liu, J. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000155747 · Cited by 52
6: Rhinitis and asthma: united airway disease
Rimmer, J., & Ruhno, J. W. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00693.x · Cited by 52
Skaarup, S. H., Schmid, J. M., Skjold, T., Graumann, O., & Hoffmann, H. J. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.002 · Cited by 51
Cox, L., Calderón, M. A., & Pfaar, O. (2012) · Immunotherapy · doi:10.2217/imt.12.36 · Cited by 51
Pfaar, O., Robinson, D. S., SAGER, A. R., & Emuzyte, R. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02413.x · Cited by 50
Henmar, H., Lund, G., Lund, L., Petersen, A., & Würtzen, P. A. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03710.x · Cited by 50
Towards evidence‐based medicine in specific grass pollen immunotherapy
Calderón, M. A., Mösges, R., Hellmich, M., & Demoly, P. M. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02292.x · Cited by 48
Zidarn, M., Košnik, M., Šilar, M., Bajrović, N., & Korošec, P. (2015) · Allergy · doi:10.1111/all.12581 · Cited by 46
Turner, P., & Kemp, A. S. (2010) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2010.01779.x · Cited by 47
Scientific Foundations of Allergen-Specific Immunotherapy for Allergic Disease
Soyka, M., van de Veen, W., Holzmann, D., Akdiş, M., & Akdiş, C. A. (2014) · CHEST Journal · doi:10.1378/chest.14-0049 · Cited by 47
Ceuppens, J. L., Bullens, D. M. A., Kleinjans, H. A. J., Werf, J. V. D., & the PURETHAL Birch Efficacy Study Group (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03379.x · Cited by 47
Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies
Sheikh, A., Nurmatov, U. B., Venderbosch, I., & Bischoff, E. W. M. A. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00071 · Cited by 47
Self-citationAbdullah, B., Latiff, A. H. A., Manuel, A. M., Jamli, F. M., Singh, H., Ismail, I. H., Jeevanan, J., Saniasiaya, J., Chen, K. W. K., Khoo, P. C., et al. (2022) · Journal of Asthma and Allergy · doi:10.2147/jaa.s374346 · Cited by 47
Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis
Gangl, K., Niederberger, V., & Valenta, R. (2013) · Clinical and Experimental Allergy · doi:10.1111/cea.12128 · Cited by 44
Immunotherapy for House Dust Mite Sensitivity: Where Are the Knowledge Gaps?
Biagtan, M. J., Viswanathan, R. K., & Bush, R. K. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0482-0 · Cited by 45
Höiby, A. ‐., Strand, V., Robinson, D. S., Sager, A., & Rak, S. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03521.x · Cited by 44
Allergic Fungal Rhinosinusitis
Ryan, M. W. (2011) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2011.03.015 · Cited by 44
The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses
Sindher, S., Long, A. J., Acharya, S., Sampath, V., & Nadeau, K. C. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8678-z · Cited by 45
Cohen, B. (2023) · Pediatrics in Review · doi:10.1542/pir.2022-005618 · Cited by 46
Didier, A. P., Wahn, U., Horak, F., & Cox, L. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.957677 · Cited by 43
Allergen immunotherapy for allergic respiratory diseases
Cappella, A., & Durham, S. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21629 · Cited by 43
Self-citationIs The Allergen Really Needed in Allergy Immunotherapy?
Kündig, T. M., Klimek, L., Schendzielorz, P., Renner, W. A., Senti, G., & Bachmann, M. F. (2014) · Current Treatment Options in Allergy · doi:10.1007/s40521-014-0038-5 · Cited by 43
Slovick, A. D., Douiri, A., Muir, R., Guerra, A., Tsioulos, K., Hay, E., Lam, E. P. S., Kelly, J., Peacock, J. L., Sun, Y., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.024 · Cited by 42
Self-citationImmunotherapy in allergic rhinitis and lower airway outcomes
Cardona, V., Luengo, O., & Labrador-Horrillo, M. (2017) · Allergy · doi:10.1111/all.12989 · Cited by 50
Sublingual grass and ragweed immunotherapy: Clinical considerations—a PRACTALL consensus report
Li, J. T., Bernstein, D. I., Calderón, M. A., Casale, T. B., Cox, L., Passalacqua, G., Pfaar, O., & Papadopoulos, N. G. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.06.046 · Cited by 41
Esch, R. E., Bush, R. K., Peden, D. B., & Lockey, R. F. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60474-7 · Cited by 41
Schmid, J. M., Würtzen, P. A., Siddhuraj, P., Jogdand, P. S., Petersen, C. G., Dahl, R., Erjefalt, J. S., & Hoffmann, H. J. (2020) · Allergy · doi:10.1111/all.14264 · Cited by 41
Novak, N., Thaçi, D., Hoffmann, M., Fölster‐Holst, R., Biedermann, T., Homey, B., Schaekel, K., Stefan, J. A., Werfel, T., Bieber, T. R. M., et al. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000320058 · Cited by 40
Immunotherapy: The Meta-Analyses. What have we Learned?
Calderón, M. A., Boyle, R. J., Penagos, M., & Sheikh, A. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.02.002 · Cited by 40
Self-citationRotiroti, G., Shamji, M. H., Durham, S. R., & Till, S. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.052 · Cited by 39
Self-citationKouser, L., Kappen, J. H., Walton, R. P., & Shamji, M. H. (2017) · Current Treatment Options in Allergy · doi:10.1007/s40521-017-0117-5 · Cited by 39
Allergen‐specific immunotherapy induces regulatory T cells in an atopic dermatitis mouse model
Shin, J. U., Kim, S. H., Noh, J. Y., Kim, J. H., Kim, H., Jeong, K. Y., Park, K. H., Lee, J., Chu, H., Lee, J., et al. (2018) · Allergy · doi:10.1111/all.13465 · Cited by 39
Update on omalizumab in allergen immunotherapy
Dantzer, J. A., & Wood, R. A. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000781 · Cited by 39
Allergen immunotherapy for allergic rhinitis
Petalas, K., & Durham, S. R. (2013) · Rhinology Journal · doi:10.4193/rhin12.86 · Cited by 39
Self-citationOptimal Management of Nasal Congestion Caused by Allergic Rhinitis in Children
Scadding, G. K. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810030-00004 · Cited by 39
Combined airways: impact of upper airway on lower airway
Fasano, M. B. (2010) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e328334aa0e · Cited by 38
Specific Allergy Immunotherapy for Allergic Rhinitis: Subcutaneous and Sublingual
Cox, L., & Wallace, D. V. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.05.001 · Cited by 38
Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis
Caruso, M., Cibella, F., Emma, R., Campagna, D., Tringali, G., Amaradio, M. D., & Polosa, R. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.034 · Cited by 38
New routes for allergen immunotherapy
Johansen, P., Moos, S. C. V., Mohanan, D., Kündig, T. M., & Senti, G. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21948 · Cited by 37
Nasser, M., Fedorowicz, Z., Aljufairi, H., & Mckerrow, W. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006989.pub2 · Cited by 33
Kappen, J. H., Diamant, Z., Agache, I. O., Bonini, M., Bousquet, J. J., Canonica, G. W., Durham, S. R., Guibas, G. V., Hamelmann, E. H., Jutel, M., et al. (2023) · Allergy · doi:10.1111/all.15817 · Cited by 39
Self-citationSpecific immunotherapy in children
Bufe, A., & Roberts, G. C. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03740.x · Cited by 36
Brehler, R., Klimek, L., Kopp, M., & Virchow, J. C., Jr. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0148 · Cited by 36
Alonso‐Coello, P., Comas, D. R., Sanabria, A. J., Plaza, V., Miravitlles, M., & Martinez, L. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2012.12.001 · Cited by 36
Update on evidence‐based reviews with recommendations in adult chronic rhinosinusitis
Orlandi, R. R., Smith, T. L., Marple, B. F., Harvey, R. J., Hwang, P. H., Kern, R. C., Kingdom, T. T., Luong, A., Rudmik, L. R., Senior, B. A., et al. (2014) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21344 · Cited by 35
Local and systemic reactions to subcutaneous allergen immunotherapy
Nacaroğlu, H. T., Erdem, S. B., Sumer, O., Karaman, S., Karkıner, C. Ş. Ü., Asi̇lsoy, S., Günay, İ., & Can, D. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.01.015 · Cited by 35
Mösges, R., Kasche, E.-M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah‐Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., et al. (2017) · Allergy · doi:10.1111/all.13358 · Cited by 35
Self-citationSubcutaneous and Sublingual Immunotherapy for Allergic Rhinitis: What is the Evidence?
Wise, S. K., & Schlosser, R. J. (2012) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2012.26.3691 · Cited by 35
Demoly, P. M., Calderón, M. A., Casale, T. B., Malling, H., & Wahn, U. (2015) · Clinical and Translational Allergy · doi:10.1186/s13601-015-0061-z · Cited by 34
Subcutaneous Immunotherapy and Sublingual Immunotherapy
Nelson, H. S., Makatsori, M., & Calderón, M. A. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.005 · Cited by 34
Diseases of the nose and paranasal sinuses in child
Stenner, M., & Rudack, C. (2014) · Europe PMC (PubMed Central) · doi:10.3205/cto000113 · Cited by 36
Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice
Copenhaver, C. C., Parker, A., & Patch, S. C. (2011) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2011.06.026 · Cited by 33
Pfaar, O., Lang, S., Pieper‐Fürst, U., Astvatsatourov, A., Gerich, F., Klimek, L., Kramer, M. F., Reydelet, Y., Shah‐Hosseini, K., & Mösges, R. (2017) · Allergy · doi:10.1111/all.13240 · Cited by 33
Leitlinie zur (allergen-)spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen
Pfaar, O., Bachert, C., Bufe, A., Buhl, R., Ebner, C., Eng, P. A., Friedrichs, F., Fuchs, T., Hamelmann, E. H., Hartwig-Bade, D., et al. (2014) · Allergo Journal · doi:10.1007/s15007-014-0707-5 · Cited by 33
Metadata
- Authors
- Calderon, M. A., Alves, B., Jacobson, M., Hurwitz, B., Sheikh, A., & Durham, S.
- Affiliations
- Royal Brompton Hospital; Department of Allergy and Respiratory Medicine; Imperial College School of Medicine at the National Heart and Lung Institute London UK SW3 6LY
- Brighton and Hove City Council (GB)
- Imperial College London (GB)
- King's College London (GB)
- University of Edinburgh (GB)
- Royal Brompton Hospital (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-01-24
- Volume
- 2009
- Issue
- 1
- Pages
- CD001936-CD001936
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC7017974
- OpenAlex
- W2153011983
- Cited by
- 678
- References
- 321
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 17 · 2023: 20 · 2022: 31 · 2021: 14 · 2020: 19 · 2019: 24 · 2018: 34 · 2017: 38 · 2016: 41 · 2015: 53 · 2014: 51 · 2013: 50 · 2012: 53
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, allergic rhinitis, tree pollen, grass pollen, weed pollen, symptom scores, medication use, quality of life, adverse events, placebo comparison, treatment efficacy and safety, treatment duration, allergen sensitivity, allergen avoidance, allergen desensitization, allergen tolerance
- MeSH terms
- Allergens, Desensitization, Immunologic, Rhinitis, Allergic, Seasonal, Humans, Injections, Subcutaneous, Pollen, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
